Search results
Edoxaban (Lixiana®) Control Low
For the quality control of edoxaban measurements using anti-Xa chromogenic assays.
vWF deficient plasma, congenital (Type 3), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 3) deficient plasma.
vWF deficient plasma, congenital (Type 2B), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2B) deficient plasma.
vWF Deficient Plasma, congenital (Type 2A), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 2A) deficient plasma.
vWF Deficient Plasma, congenital (Type 1), frozen
For all in-vitro -analyses that require congenital human von Willebrand factor (Type 1) deficient plasma.
Factor VIII Inhibitor Plasma congenital, frozen
For research use only.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra®, Orgaran®, rivaroxaban (Xarelto®), apixaban (Eliquis®) and edoxaban (Lixiana®) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
Factor VIII deficient plasma congenital (frozen)
For all in-vitro -analyses that require congenital human factor VIII deficient plasma.
Factor VIII deficient plasma congenital, pooled (frozen)
For all in-vitro -analyses that require congenital pooled human factor VIII deficient plasma.
LIAPHEN vWF:Ag
Diagnosis of von Willebrand disease. Determination of high vWF antigen levels associated with cardiovascular diseases.